Matrix stiffness may drive multi-cellular crosstalk via YAP signaling in biliary atresia liver fibrosis: a mechanistic review
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Background: Biliary atresia (BA) is a devastating liver disease in infants. It leads to progressive cholangitis and fibrosis. In BA, the liver builds up too much extracellular matrix (ECM) and crosslinks it. That makes the tissue stiffer over time—a physical hallmark of fibrosis. Mechanistic Framework: Most of the current evidence comes from non-BA models and lab studies. Those studies hint that higher matrix stiffness might act as a mechanical trigger. It could activate YAP signaling, which then organizes pathological crosstalk among hepatocytes, cholangiocytes, and hepatic stellate cells (HSCs). Direct proof from BA tissue is still missing. Key Findings: This review looks at how matrix stiffness—through YAP-driven mechanotransduction—may drive pro-fibrotic changes in hepatocytes, cholangiocytes, and HSCs. We propose a self-reinforcing, multi-cellular pro-fibrotic network: stiff ECM turns on YAP in hepatocytes (which release inflammatory signals) and cholangiocytes (which secrete pro-fibrotic factors). Those activated HSCs then deposit and crosslink even more ECM. That raises stiffness further and locks YAP activation in all 3 cell types. Right now, this model rests mostly on indirect evidence. It needs BA-specific testing. Therapeutic Implications: We also touch on new strategies that target this mechanobiological circuit—YAP inhibitors and matrix-softening methods. Conclusion: By pulling together what we know about ECM mechanics, YAP mechanotransduction, and cell-cell crosstalk, this review points to the matrix stiffness–YAP axis as a likely key driver of BA fibrosis. It also looks like a promising treatment target.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Origin of myofibroblasts in the fibrotic liver in mice
Iwaisako, K., Jiang, C., Zhang, M., Cong, M., Moore-Morris, T. J., Park, T. J., Liu, X., Xu, J., Wang, P., Paik, Y.-H., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400062111 · Cited by 535 · cited 1×
“Both can turn into myofibroblasts, but their origins, markers, and responses to injury differ (Iwaisako et al., 2014).”
The Hippo pathway effector YAP controls mouse hepatic stellate cell activation
Mannaerts, I., Leite, S. B., Verhulst, S., Claerhout, S., Eysackers, N., Thoen, L. F. R., Hoorens, A., Reynaert, H., Halder, G., & van Grunsven, L. A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.04.011 · Cited by 410
Mechanoregulation of YAP and TAZ in Cellular Homeostasis and Disease Progression
Cai, X., Wang, K.-C., & Meng, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.673599 · Cited by 304
Cai, S.-Y., Ouyang, X., Chen, Y., Soroka, C. J., Wang, J., Mennone, A., Wang, Y., Mehal, W. Z., Jain, D., & Boyer, J. L. (2017) · JCI Insight · doi:10.1172/jci.insight.90780 · Cited by 255
Chu, A. S., Diaz, R., Hui, J.-J., Yanger, K., Zong, Y., Alpini, G., Stanger, B. Z., & Wells, R. G. (2011) · Hepatology · doi:10.1002/hep.24206 · Cited by 208
Hippo signalling in the liver: role in development, regeneration and disease
Russell, J. O., & Camargo, F. D. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00571-w · Cited by 207
Tam, P. K. H., Wells, R. G., Tang, C. S.-M., Lui, V. C. H., Hukkinen, M., Luque, C. D., Coppi, P. D., Mack, C. L., Pakarinen, M. P., & Davenport, M. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00533-x · Cited by 192
An overview of signaling pathways regulating YAP/TAZ activity
Heng, B. C., Zhang, X., Aubel, D., Bai, Y., Li, X., Yan, W., Fussenegger, M., & Deng, X. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03579-8 · Cited by 161
Uchihara, T., Miyake, K., Yonemura, A., Komohara, Y., Itoyama, R., Koiwa, M., Yasuda, T., Arima, K., Harada, K., Eto, K., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-3803 · Cited by 158
Targeting acid ceramidase inhibits YAP/TAZ signaling to reduce fibrosis in mice
Alsamman, S., Christenson, S. A., Yu, A., Ayad, N. M. E., Mooring, M. S., Segal, J. M., Hu, J. K.-H., Schaub, J. R., Ho, S. S., Rao, V., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay8798 · Cited by 122
The role of bile acids in cholestatic liver injury
Cai, S.-Y., & Boyer, J. L. (2021) · Annals of Translational Medicine · doi:10.21037/atm-20-5110 · Cited by 120
New Insights into Hippo/YAP Signaling in Fibrotic Diseases
Mia, M. M., & Singh, M. K. (2022) · Cells · doi:10.3390/cells11132065 · Cited by 116
Zheng, Y., Zhou, R., Cai, J., Yang, N., Wen, Z., Zhang, Z., Sun, H., Huang, G., Guan, Y., Huang, N., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0025 · Cited by 105
Hippo signaling pathway and respiratory diseases
Tang, W., Li, M., Yangzhong, X., Zhang, X., Zu, A., Hou, Y., Li, L., & Sun, S. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-01020-6 · Cited by 90
Biomaterials Regulate Mechanosensors YAP/TAZ in Stem Cell Growth and Differentiation
Virdi, J. K., & Pethe, P. S. (2020) · Tissue Engineering and Regenerative Medicine · doi:10.1007/s13770-020-00301-4 · Cited by 81
Targeting the Hippo pathway in cancer
Harvey, K. F., & Tang, T. T.-L. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01234-0 · Cited by 80
Substrate Stiffness-Driven Membrane Tension Modulates Vesicular Trafficking via Caveolin-1
Lachowski, D., Matellan, C., Gopal, S., Cortes, E., Robinson, B. K., Saiani, A., Miller, A. F., Stevens, M. M., & del Río Hernández, A. E. (2022) · ACS Nano · doi:10.1021/acsnano.1c10534 · Cited by 76
Mechanical homeostasis imbalance in hepatic stellate cells activation and hepatic fibrosis
Zhao, Y.-Q., Deng, X.-W., Xu, G.-Q., Lin, J., Lu, H.-Z., & Chen, J. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1183808 · Cited by 71
Nuclear deformation mediates liver cell mechanosensing in cirrhosis
Guixé-Muntet, S., Ortega-Ribera, M., Wang, C., Selicean, S., Andreu, I., Kechagia, J. Z., Fondevila, C., Roca-Cusachs, P., Dufour, J.-F., Bosch, J., et al. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100145 · Cited by 69
Zhubanchaliyev, A., Temirbekuly, A., Kongrtay, K., Wanshura, L. C., & Kunz, J. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00462 · Cited by 67
Liu, Z., Mo, H., Liu, R., Niu, Y., Chen, T., Xu, Q., Tu, K., & Yang, N. (2021) · Cell Death & Disease · doi:10.1038/s41419-021-04418-9 · Cited by 67 · cited 1×
“Compared to cells on soft matrices, HSCs on stiff matrices show higher levels of α -SMA and collagen I (Liu et al., 2021; Jia et al., 2026).”
Zhang, K., Chang, Y., Shi, Z., Han, X., Han, Y., Yao, Q., Hu, Z., Cui, H., Zheng, L., Han, T., et al. (2016) · Scientific Reports · doi:10.1038/srep30029 · Cited by 61
Hippo-Yap/Taz signalling in zebrafish regeneration
Riley, S. E., Feng, Y., & Hansen, C. G. (2022) · npj Regenerative Medicine · doi:10.1038/s41536-022-00209-8 · Cited by 58
Regulation and mechanism of YAP/TAZ in the mechanical microenvironment of stem cells (Review)
Li, Y., Wang, J., & Zhong, W. (2021) · Molecular Medicine Reports · doi:10.3892/mmr.2021.12145 · Cited by 57
Yang, P., Zhang, D., Wang, T., Ji, J., Jin, C., Peng, C., Tan, Y., Zhou, J., Wang, L., Feng, Y., et al. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05240-7 · Cited by 57
Liu, J., Wang, J., Liu, Y., Xie, S.-A., Zhang, J., Zhao, C., Zhou, Y., Pang, W., Yao, W., Peng, Q., et al. (2022) · Circulation Research · doi:10.1161/circresaha.122.322113 · Cited by 57
Targeting the Hippo pathway in heart repair
Meng, F., Xie, B., & Martin, J. F. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab291 · Cited by 56
Zarka, M., Étienne, F., Bourmaud, M., Szondi, D. C., Schwartz, J., Kampmann, K., Hélary, C., Rannou, F., Haÿ, E., & Cohen-Solal, M. E. (2021) · Laboratory Investigation · doi:10.1038/s41374-021-00668-5 · Cited by 54
Li, W., Li, P., Li, N., Du, Y., Lü, S., Elad, D., & Long, M. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00379.2019 · Cited by 53
Caon, E., Martins, M., Hodgetts, H., Blanken, L., Vilia, M. G., Levi, A., Thanapirom, K., Al-Akkad, W., Abu-Hanna, J., Baselli, G., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.01.032 · Cited by 46
Context-dependent transcriptional regulations of YAP/TAZ in stem cell and differentiation
Luo, J., & Li, P. (2022) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02686-y · Cited by 44
Regulators, functions, and mechanotransduction pathways of matrix stiffness in hepatic disease
Guo, T., Wantono, C., Tan, Y., Deng, F., Duan, T., & Liu, D. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1098129 · Cited by 44
Galina, P., Alexopoulou, E., Mentessidou, A., Mirilas, P., Zellos, A., Lykopoulou, L., Patereli, A., Salpasaranis, K., Kelekis, N., & Zarifi, M. K. (2021) · Pediatric Radiology · doi:10.1007/s00247-020-04959-9 · Cited by 40
Central role for cholangiocyte pathobiology in cholestatic liver diseases
Jalan-Sakrikar, N., Guicciardi, M. E., O’Hara, S. P., Azad, A., LaRusso, N. F., Gores, G. J., & Huebert, R. C. (2025) · Hepatology · doi:10.1097/hep.0000000000001093 · Cited by 38
Can a fibrotic liver afford epithelial-mesenchymal transition?
Munker, S., Wu, Y.-L., Ding, H.-G., Liebe, R., & Weng, H.-L. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i26.4661 · Cited by 37
Predicting native liver injury and survival in biliary atresia
Hukkinen, M., Pihlajoki, M., & Pakarinen, M. P. (2020) · Seminars in Pediatric Surgery · doi:10.1016/j.sempedsurg.2020.150943 · Cited by 37
Xiao, M.-H., Ma, D., Wu, S., Huang, Z., Liang, P., Chen, H., Zhong, Z., Li, W., Wang, F., Tang, Y., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000001064 · Cited by 37
Vitamin D receptor attenuates carbon tetrachloride-induced liver fibrosis via downregulation of YAP
Wang, P., Li, J., Ji, M., Pan, J., Cao, Y., Kong, Y., Zhu, L., Li, J., Li, B., Chang, L., et al. (2024) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2024.135480 · Cited by 36
Hepatocyte CYR61 polarizes profibrotic macrophages to orchestrate NASH fibrosis
Mooring, M., Yeung, G. A., Luukkonen, P., Liu, S., Akbar, M. W., Zhang, G. J., Balogun, O., Yu, X., Mo, R., Nejak-Bowen, K., et al. (2023) · Science Translational Medicine · doi:10.1126/scitranslmed.ade3157 · Cited by 33 · cited 2×
“Direct evidence from a NASH mouse model shows that hepatocyte CYR61 secretion promotes pro-inflammatory macrophage polarization and liver fibrosis (Mooring et al., 2023).”
Leung, D. H., Devaraj, S., Goodrich, N. P., Chen, X., Rajapakshe, D., Ye, W., Andreev, V. P., Minard, C. G., Guffey, D., Molleston, J. P., et al. (2022) · Hepatology · doi:10.1002/hep.32777 · Cited by 32
Stretch increases alveolar type 1 cell number in fetal lungs through ROCK-Yap/Taz pathway
Nguyen, T. M., van der Merwe, J., Elowsson, L., Larsson‐Callerfelt, A., Deprest, J. A., Westergren‐Thorsson, G., & Toelen, J. (2021) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00484.2020 · Cited by 31
Role of YAP1 Signaling in Biliary Development, Repair, and Disease
Molina, L. M., Nejak‐Bowen, K. N., & Monga, S. P. (2022) · Seminars in Liver Disease · doi:10.1055/s-0041-1742277 · Cited by 29
Wang, L., Huang, Y., Chen, J., Gao, J., Chen, S., Zhao, M., Lin, J., Zhou, S., Shen, Y., & Cheng, Y. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1635763 · Cited by 26
Zhang, X., Li, P., Zhou, J., Zhang, Z., Wu, H., Shu, X., Li, W., Wu, Y. C., Lü, S., Lü, D., et al. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2023.122462 · Cited by 24
Interplay between YAP/TAZ and metabolic dysfunction-associated steatotic liver disease progression
Lee, N. Y., Choi, M. G., Lee, E. J., & Koo, J. H. (2024) · Archives of Pharmacal Research · doi:10.1007/s12272-024-01501-5 · Cited by 20
AMPK stimulation inhibits YAP/TAZ signaling to ameliorate hepatic fibrosis
Shihan, M. H., Sharma, S. K., Cable, C., Prathigudupu, V., Chen, A. J., Mattis, A. N., & Chen, J. Y. (2024) · Scientific Reports · doi:10.1038/s41598-024-55764-5 · Cited by 19
Chen, G., Deng, Y., Xia, B., & Lv, Y. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202202560 · Cited by 18
Yokoyama, S., Ishizu, Y., Honda, T., Imai, N., Ito, T., Yamamoto, K., Muto, H., Shirota, C., Tainaka, T., Sumida, W., et al. (2023) · Hepatology Research · doi:10.1111/hepr.13976 · Cited by 18
Wu, Q., Sun, Q., Zhang, Q., Wang, N., Lv, W., & Han, D. C. (2024) · Pharmaceuticals · doi:10.3390/ph17050644 · Cited by 18
Masyuk, A. I., Masyuk, T. V., Trussoni, C. E., Pirius, N., & LaRusso, N. F. (2021) · Hepatology · doi:10.1002/hep.32298 · Cited by 16
JCAD deficiency attenuates activation of hepatic stellate cells and cholestatic fibrosis
Xie, L., Chen, H., Zhang, L., Zhou, Y., Yang, Y.-Y., Liu, C., Wang, Y., Ma, Y., Yan, Y.-J., Ding, J., et al. (2024) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2023.0506 · Cited by 16
FAK mediates mechanical signaling to maintain epithelial homeostasis through YAP/TAZ-TEADs
Yang, P., Yuan, Q., Zhou, S., Gan, J., Shen, Z., Xia, X., Jiang, Y., Chen, Q., Yao Zong, Y. U. A. N., He, R., et al. (2025) · Histochemistry and Cell Biology · doi:10.1007/s00418-025-02360-x · Cited by 16
The LINC Complex Assists the Nuclear Import of Mechanosensitive Transcriptional Regulators
Takata, T., & Matsumura, M. (2022) · Results and problems in cell differentiation · doi:10.1007/978-3-031-06573-6_11 · Cited by 13
ZNF469 is a profibrotic regulator of extracellular matrix in hepatic stellate cells
Ariyachet, C., Nokkeaw, A., Boonkaew, B., & Tangkijvanich, P. (2024) · Journal of Cellular Biochemistry · doi:10.1002/jcb.30578 · Cited by 13
Sakai, M., & YOSHIMURA, R. (2020) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b20-00815 · Cited by 12
Long-term follow-up of biliary atresia using liver transient elastography
Yeung, F., Fung, A. C. H., Chung, B., Chu, Y. Y. L., Seto, W., & Wong, K. K. (2022) · Pediatric Surgery International · doi:10.1007/s00383-022-05137-8 · Cited by 12
Aoyama, S., Kido, Y., Kanamoto, M., Naito, M., Nakanishi, M., Kanna, M., Yamamotoya, T., Asano, T., & Nakatsu, Y. (2023) · Experimental Cell Research · doi:10.1016/j.yexcr.2023.113544 · Cited by 12
Gao, K., Zhang, W., Xu, D., Zhao, M., Tao, X., Lu, Y., & Wang, J. (2025) · Chinese Medicine · doi:10.1186/s13020-025-01090-5 · Cited by 10
Rodríguez-Rodríguez, D. R., Lozano-Sepúlveda, S. A., Delgado-Montemayor, C., de Torres, N. H. W., Cordero‐Pérez, P., & Rivas-Estilla, A. M. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.10.009 · Cited by 9
Atlas of mildly and highly insoluble matrisome driving liver fibrosis
Zhang, W., Zhang, N., Wu, W., Li, H., You, H., & Chen, W. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1435359 · Cited by 8
Nikolić, I., & Morici, L. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178645 · Cited by 8
Han, H., Yu, D., Liu, Y., Jia, H., & Liu, W. (2025) · Science Advances · doi:10.1126/sciadv.adz4126 · Cited by 7 · cited 2×
“That builds a self-amplifying positive feedback loop: Stiffness → YAP → ECM production/crosslinking → Increased stiffness (Han et al., 2025; Caon et al., 2024).”
Bai, J., Yang, Z., Wang, P., Qian, B., Jiang, Z., Xu, T., Pu, H., Ye, M., Du, Y., & Fu, W. (2025) · Food & Function · doi:10.1039/d5fo01024a · Cited by 6
Ueda, K., Yamada, Y., Tanaka, H., Sato, T., Sasaki, J., Sakamoto, S., Minomi, K., Yamada, H., & Sugimoto, M. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102768 · Cited by 6
Luteolin for the Treatment of Organ Fibrosis: A Mini Review
Wang, N., & Lan, W. (2025) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575408729250811073556 · Cited by 5
EP300/YAP1-SERPINE1 Signaling Regulates Ductular Reaction and Liver Fibrosis in Biliary Atresia
Zhu, Z., Lu, C., Lv, X., Lü, Y., Zhu, W., Zhu, Y., Zhang, R., Ding, Z., Xie, H. Q., & Tang, W. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101640 · Cited by 5
Xie, Y., Hu, B., Gao, Y., Tang, Y., Chen, G., Shen, J., Jiang, Z., Jiang, H., Han, J., Yan, J., et al. (2022) · Animal Cells and Systems · doi:10.1080/19768354.2022.2139755 · Cited by 4
Yang, T., Shen, Y., Mou, W., Zhao, J., Wang, H., Chen, Y., Zhang, L., Fu, L., Wang, D., & Huang, J. (2025) · Pediatric Research · doi:10.1038/s41390-025-04304-6 · Cited by 4
Li, H., Gupta, K., Wang, Z., Llewellyn, J., Jin, H., Tenney, S. A., Wells, R. G., & Foston, M. B. (2026) · Analytica Chimica Acta · doi:10.1016/j.aca.2026.345175 · Cited by 2
Biliary Atresia–Extracellular Matrix Score
Liang, N. E., Guo, J. L., Griffin, M., Bauer-Rowe, K. E., Narang, A., Januszyk, M., Fell, G. L., Dunn, J., Chao, S. D., Tan, S. Y., et al. (2025) · Annals of Surgery · doi:10.1097/sla.0000000000006698 · Cited by 1
Saad, K., Embaby, M. M., Alruwaili, T. A. M., Elhoufey, A. A., Temsah, M.-H. A., Hussein, W. M., Abdelsaboor, M., & Mahmoud, K. H. (2025) · Pediatric Research · doi:10.1038/s41390-025-04242-3 · Cited by 1
Meng, L., Du, M., Chen, G., Dong, R., Qian, T., Shen, Z., Wang, J., & Zheng, S. (2025) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2025.162492 · Cited by 1
Du, X., Gao, Y., Song, S., Hui, Q., Wang, Z., Ji, M., Li, M., Duan, S., Liu, S., Wang, Z., et al. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08043-8 · Cited by 1
Jia, S., Niu, Y., Nuernijiati, N., Zhang, C., Li, J., & Tu, K. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05450-5 · Cited by 1
Queiroz, T. C. N., PINTO-SILVA, R. A., Fagundes, E. D. T., Ferreira, G. D., Ferreira, A. C., & Ferreira, A. R. (2026) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.24612025-048 · Cited by 1
Cited by
Still being checked.
Metadata
- Authors
- Cheng, J.
- Affiliations
- First Affiliated Hospital of Xi'an Jiaotong University (CN)
- Corresponding author
- Cheng, Jiwen
- ORCID
- Cheng, Jiwen
- Venue
- Frontiers in Cell and Developmental Biology
- Publisher
- Frontiers Media SA
- Published
- 2026-07-01
- Volume
- 14
- Pages
- 1842681-1842681
- ISSN
- 2296-634X (ISSN-L)
- PMC
- PMC13368877
- OpenAlex
- W7166826835
- Cited by
- 0
- References
- 75
- FWCI
- 0.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Cell and Developmental Biology (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- Funders
- National Natural Science Foundation of China (81800450)
- Topics
- Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Keywords
- biliary atresia, liver fibrosis, extracellular matrix stiffness, YAP signaling, mechanotransduction, hepatic stellate cells, cholangiocytes, hepatocytes, YAP inhibitor, matrix softening
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.